Literature DB >> 28348076

The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition.

Min Liu1, Cai Yuan2, Jan K Jensen3, Baoyu Zhao4, Yunbin Jiang1, Longguang Jiang5, Mingdong Huang6.   

Abstract

Hepatocyte growth factor activator inhibitor 1 (HAI-1) is a membrane-bound multidomain protein essential to the integrity of the basement membrane during placental development and is also important in maintaining postnatal homeostasis in many tissues. HAI-1 is a Kunitz-type serine protease inhibitor, and soluble fragments of HAI-1 with variable lengths have been identified in vivo The full-length extracellular portion of HAI-1 (sHAI-1) shows weaker inhibitory activity toward target proteases than the smaller fragments, suggesting auto-inhibition of HAI-1. However, this possible regulatory mechanism has not yet been evaluated. Here, we solved the crystal structure of sHAI-1 and determined the solution structure by small-angle X-ray scattering. These structural analyses revealed that, despite the presence of long linkers, sHAI-1 exists in a compact conformation in which sHAI-1 active sites in Kunitz domain 1 are sterically blocked by neighboring structural elements. We also found that in the presence of target proteases, sHAI-1 adopts an extended conformation that disables the auto-inhibition effect. Our results also reveal the roles of non-inhibitory domains of this multidomain protein and explain the low activity of the full-length protein. The structural insights gained here improve our understanding of the regulation of HAI-1 inhibitory activities and point to new approaches for better controlling these activities.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  conformational change; crystal structure; protein crystallization; protein dynamic; protein structure; small-angle X-ray scattering (SAXS)

Mesh:

Substances:

Year:  2017        PMID: 28348076      PMCID: PMC5437246          DOI: 10.1074/jbc.M117.779256

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Role of the stem domain of matriptase in the interaction with its physiological inhibitor, hepatocyte growth factor activator inhibitor type I.

Authors:  Kenji Kojima; Satoshi Tsuzuki; Tohru Fushiki; Kuniyo Inouye
Journal:  J Biochem       Date:  2009-03-10       Impact factor: 3.387

2.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.

Authors:  K C Garcia; M Degano; L R Pease; M Huang; P A Peterson; L Teyton; I A Wilson
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

3.  Understanding the role of domain-domain linkers in the spatial orientation of domains in multi-domain proteins.

Authors:  Ramachandra M Bhaskara; Alexandre G de Brevern; Narayanaswamy Srinivasan
Journal:  J Biomol Struct Dyn       Date:  2012-12-19

4.  Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form.

Authors:  T Shimomura; K Denda; T Kawaguchi; K Matsumoto; K Miyazawa; N Kitamura
Journal:  J Biochem       Date:  1999-11       Impact factor: 3.387

5.  Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

Authors:  Daniel Kirchhofer; Mark Peek; Michael T Lipari; Karen Billeci; Bin Fan; Paul Moran
Journal:  FEBS Lett       Date:  2005-03-28       Impact factor: 4.124

6.  Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa.

Authors:  H Itoh; H Kataoka; M Tomita; R Hamasuna; Y Nawa; N Kitamura; M Koono
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-04       Impact factor: 4.052

7.  Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Virote Sriuranpong; Vivien Redeye; Tricia Murdock; Beth Burke; Boye S Nielsen; J Silvio Gutkind; Thomas H Bugge
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

8.  Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin.

Authors:  Bin Fan; Thomas D Wu; Wei Li; Daniel Kirchhofer
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

9.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

10.  Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.

Authors:  Roman Szabo; Katiuchia Uzzun Sales; Peter Kosa; Natalia A Shylo; Sine Godiksen; Karina K Hansen; Stine Friis; J Silvio Gutkind; Lotte K Vogel; Edith Hummler; Eric Camerer; Thomas H Bugge
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

View more
  3 in total

1.  Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the O-glycoproteome by inducible expression in isogenic cell lines.

Authors:  John Hintze; Zilu Ye; Yoshiki Narimatsu; Thomas Daugbjerg Madsen; Hiren J Joshi; Christoffer K Goth; Adam Linstedt; Collin Bachert; Ulla Mandel; Eric P Bennett; Sergey Y Vakhrushev; Katrine T Schjoldager
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

2.  Differential subcellular distribution renders HAI-2 a less effective protease inhibitor than HAI-1 in the control of extracellular matriptase proteolytic activity.

Authors:  Yi-Lin Chiu; Yi-Ying Wu; Robert B Barndt; Yu-Wen Lin; Hou-Ping Sytwo; Amy Cheng; Kacy Yang; Khee-Siang Chan; Jehng-Kang Wang; Michael D Johnson; Chen-Yong Lin
Journal:  Genes Dis       Date:  2020-12-09

3.  Targeted HAI-2 deletion causes excessive proteolysis with prolonged active prostasin and depletion of HAI-1 monomer in intestinal but not epidermal epithelial cells.

Authors:  Robert B Barndt; Mon-Juan Lee; Nanxi Huang; Dajun D Lu; See-Chi Lee; Po-Wen Du; Chun-Chia Chang; Ping-Feng B Tsai; Yu-Siou K Huang; Hao-Ming Chang; Jehng-Kang Wang; Chih-Hsin Lai; Michael D Johnson; Chen-Yong Lin
Journal:  Hum Mol Genet       Date:  2021-09-15       Impact factor: 5.121

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.